These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24950364)

  • 1. Stabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugs.
    Zhang P; Forsgren J; Strømme M
    Int J Pharm; 2014 Sep; 472(1-2):185-91. PubMed ID: 24950364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-Controlled Drug Release From the Mesoporous Magnesium Carbonate Upsalite(®).
    Zhang P; Zardán Gómez de la Torre T; Forsgren J; Bergström CAS; Strømme M
    J Pharm Sci; 2016 Feb; 105(2):657-663. PubMed ID: 26087956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amorphous magnesium carbonate nanoparticles with strong stabilizing capability for amorphous ibuprofen.
    Yang J; Alvebratt C; Lu X; Bergström CAS; Strømme M; Welch K
    Int J Pharm; 2018 Sep; 548(1):515-521. PubMed ID: 29981897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties.
    Shen SC; Ng WK; Chia L; Dong YC; Tan RB
    J Pharm Sci; 2010 Apr; 99(4):1997-2007. PubMed ID: 19816955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous calcium carbonate as a phase stabilizer of amorphous celecoxib--an approach to increase the bioavailability of poorly soluble pharmaceutical substances.
    Forsgren J; Andersson M; Nilsson P; Mihranyan A
    Adv Healthc Mater; 2013 Nov; 2(11):1469-76. PubMed ID: 23703752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size.
    Shen SC; Ng WK; Chia L; Hu J; Tan RB
    Int J Pharm; 2011 May; 410(1-2):188-95. PubMed ID: 21419202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen-cationic dextran conjugate crystanules.
    Abioye AO; Kola-Mustapha A; Chi GT; Ilya S
    Int J Pharm; 2014 Aug; 471(1-2):453-77. PubMed ID: 24886691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supersaturation of poorly soluble drugs induced by mesoporous magnesium carbonate.
    Zhang P; Zardán Gómez de la Torre T; Welch K; Bergström C; Strømme M
    Eur J Pharm Sci; 2016 Oct; 93():468-74. PubMed ID: 27590126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica material TUD-1 as a drug delivery system.
    Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amine modification of mesoporous magnesium carbonate on controlled drug release.
    Vall M; Zhang P; Gao A; Frykstrand S; Cheung O; Strømme M
    Int J Pharm; 2017 May; 524(1-2):141-147. PubMed ID: 28359819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a simple paste for 3D printing of drug formulations containing a mesoporous material loaded with a poorly water-soluble drug.
    Katsiotis CS; Tikhomirov E; Leliopoulos C; Strømme M; Welch K
    Eur J Pharm Biopharm; 2024 May; 198():114270. PubMed ID: 38537908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
    Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel mesoporous silica nanoparticles for loading and release of ibuprofen.
    Zhang H; Li Z; Xu P; Wu R; Wang L; Xiang Y; Jiao Z
    J Control Release; 2011 Nov; 152 Suppl 1():e38-9. PubMed ID: 22195911
    [No Abstract]   [Full Text] [Related]  

  • 16. Formation of long-term stable amorphous ibuprofen nanoparticles via antisolvent melt precipitation (AMP).
    Melzig S; Finke JH; Schilde C; Kwade A
    Eur J Pharm Biopharm; 2018 Oct; 131():224-231. PubMed ID: 30149060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
    Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
    J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
    Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
    J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.